IT1296984B1 - Derivati ftalazinici inibitori della fosfodiesterasi 4 - Google Patents

Derivati ftalazinici inibitori della fosfodiesterasi 4

Info

Publication number
IT1296984B1
IT1296984B1 IT97MI002806A ITMI972806A IT1296984B1 IT 1296984 B1 IT1296984 B1 IT 1296984B1 IT 97MI002806 A IT97MI002806 A IT 97MI002806A IT MI972806 A ITMI972806 A IT MI972806A IT 1296984 B1 IT1296984 B1 IT 1296984B1
Authority
IT
Italy
Prior art keywords
phenyl
alkyl
group
phosphodiesterase
aryl
Prior art date
Application number
IT97MI002806A
Other languages
English (en)
Inventor
Mauro Napoletano
Gabriele Norcini
Daniela Botta
Giancarlo Grancini
Gabriele Morazzoni
Francesco Santangelo
Herreo Jorge G Siro
Navio Jose Luis Garcia
Julio G Alvarez-Builla
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IT97MI002806A priority Critical patent/IT1296984B1/it
Application filed by Zambon Spa filed Critical Zambon Spa
Priority to ES98966900T priority patent/ES2216354T3/es
Priority to DK98966900T priority patent/DK1042300T3/da
Priority to PCT/EP1998/008291 priority patent/WO1999032456A1/en
Priority to EP98966900A priority patent/EP1042300B1/en
Priority to DE69821650T priority patent/DE69821650T2/de
Priority to PT98966900T priority patent/PT1042300E/pt
Priority to AT98966900T priority patent/ATE259356T1/de
Priority to JP2000525393A priority patent/JP2001526270A/ja
Priority to US09/581,506 priority patent/US6589951B1/en
Priority to AU26132/99A priority patent/AU2613299A/en
Publication of ITMI972806A1 publication Critical patent/ITMI972806A1/it
Application granted granted Critical
Publication of IT1296984B1 publication Critical patent/IT1296984B1/it
Priority to US10/441,177 priority patent/US20040043999A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/34Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
IT97MI002806A 1997-12-19 1997-12-19 Derivati ftalazinici inibitori della fosfodiesterasi 4 IT1296984B1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT97MI002806A IT1296984B1 (it) 1997-12-19 1997-12-19 Derivati ftalazinici inibitori della fosfodiesterasi 4
JP2000525393A JP2001526270A (ja) 1997-12-19 1998-12-17 フタラジン誘導体ホスホジエステラーゼ4阻害剤
PCT/EP1998/008291 WO1999032456A1 (en) 1997-12-19 1998-12-17 Phthalazine derivatives phosphodiesterase 4 inhibitors
EP98966900A EP1042300B1 (en) 1997-12-19 1998-12-17 Phthalazine derivatives useful as phosphodiesterase 4 inhibitors
DE69821650T DE69821650T2 (de) 1997-12-19 1998-12-17 Phtalazin derivate wirksam als phosphodiesterase 4 inhibitoren
PT98966900T PT1042300E (pt) 1997-12-19 1998-12-17 Derivados ftalazina inibidores da fosfodiesterase 4
ES98966900T ES2216354T3 (es) 1997-12-19 1998-12-17 Derivados de ftalazina utiles como inhibidores de fosfodiesterasa-4.
DK98966900T DK1042300T3 (da) 1997-12-19 1998-12-17 Phthalazinderivater, der kan anvendes som hæmmere af phosphodiesterase 4
US09/581,506 US6589951B1 (en) 1997-12-19 1998-12-17 Phthalazine derivatives as phosphodiesterase 4 inhibitors
AU26132/99A AU2613299A (en) 1997-12-19 1998-12-17 Phthalazine derivatives phosphodiesterase 4 inhibitors
AT98966900T ATE259356T1 (de) 1997-12-19 1998-12-17 Phtalazin derivate wirksam als phosphodiesterase 4 inhibitoren
US10/441,177 US20040043999A1 (en) 1997-12-19 2003-05-20 Phthalazine derivatives as phosphodiesterase 4-inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI002806A IT1296984B1 (it) 1997-12-19 1997-12-19 Derivati ftalazinici inibitori della fosfodiesterasi 4

Publications (2)

Publication Number Publication Date
ITMI972806A1 ITMI972806A1 (it) 1999-06-19
IT1296984B1 true IT1296984B1 (it) 1999-08-03

Family

ID=11378396

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97MI002806A IT1296984B1 (it) 1997-12-19 1997-12-19 Derivati ftalazinici inibitori della fosfodiesterasi 4

Country Status (11)

Country Link
US (2) US6589951B1 (it)
EP (1) EP1042300B1 (it)
JP (1) JP2001526270A (it)
AT (1) ATE259356T1 (it)
AU (1) AU2613299A (it)
DE (1) DE69821650T2 (it)
DK (1) DK1042300T3 (it)
ES (1) ES2216354T3 (it)
IT (1) IT1296984B1 (it)
PT (1) PT1042300E (it)
WO (1) WO1999032456A1 (it)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1296984B1 (it) * 1997-12-19 1999-08-03 Zambon Spa Derivati ftalazinici inibitori della fosfodiesterasi 4
ITMI981671A1 (it) * 1998-07-21 2000-01-21 Zambon Spa Derivati ftalazinici inibitori della fosfodisterasi 4
ITMI981670A1 (it) 1998-07-21 2000-01-21 Zambon Spa Derivati ftalazinici inibitori della fosfodiesterasi 4
IT1303272B1 (it) 1998-10-29 2000-11-06 Zambon Spa Derivati triciclici inibitori della fosfodiesterasi 4
DE19963607B4 (de) * 1999-12-23 2005-12-15 Schering Ag Verfahren zur Herstellung von 4-(Heteroaryl-methyl) halogen-1(2H)-phthalazinonen
ITMI20022739A1 (it) * 2002-12-23 2004-06-24 Zambon Spa Derivati ftalazinici inibitori della fosfodiesterasi 4.
FR2868780B1 (fr) * 2004-04-13 2008-10-17 Sanofi Synthelabo Derives de la 1-amino-phthalazine, leur preparation et leur application en therapeutique
WO2006074223A2 (en) * 2005-01-03 2006-07-13 Myriad Genetics, Inc. Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof
US7759337B2 (en) * 2005-03-03 2010-07-20 Amgen Inc. Phthalazine compounds and methods of use
EP1991531A1 (en) * 2006-02-28 2008-11-19 Amgen Inc. Cinnoline and quinoxaline derivates as phosphodiesterase 10 inhibitors
US8044041B2 (en) * 2006-11-15 2011-10-25 Forest Laboratories Holdings Limited Phthalazine derivatives as inhibitors of protein kinase
RU2009141592A (ru) * 2007-04-11 2011-05-20 Алькон Рисерч, Лтд. (Us) ПРИМЕНЕНИЕ ИНГИБИТОРА TNFα В СОЧЕТАНИИ С АНТИГИСТАМИННЫМ СРЕДСТВОМ ДЛЯ ЛЕЧЕНИЯ АЛЛЕРГИЧЕСКОГО РИНИТА И АЛЛЕРГИЧЕСКОГО КОНЪЮНКТИВИТА
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
WO2010042649A2 (en) * 2008-10-10 2010-04-15 Amgen Inc. PHTHALAZINE COMPOUNDS AS p38 MAP KINASE MODULATORS AND METHODS OF USE THEREOF
WO2010042646A1 (en) 2008-10-10 2010-04-15 Amgen Inc. Aza- and diaza-phthalazine compounds as p38 map kinase modulators and methods of use thereof
EP2272831A1 (en) * 2009-06-26 2011-01-12 Prime European Therapeuticals S.p.A. Process for the preparation of arylpyridinyl compounds
BR112012007091A2 (pt) * 2009-10-01 2016-04-19 Alcon Res Ltd composições de olopatadina e seus usos
KR20160023854A (ko) * 2013-06-24 2016-03-03 메르크 파텐트 게엠베하 프탈라진 유도체
EP3080085B1 (en) * 2013-12-09 2019-08-14 UCB Biopharma SPRL Fused bicyclic heteroaromatic derivatives as modulators of tnf activity
JP2022515838A (ja) 2018-12-28 2022-02-22 リジェネロン・ファーマシューティカルズ・インコーポレイテッド アラキドン酸15-リポキシゲナーゼ(alox15)阻害剤による呼吸器障害の治療

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2063249A (en) * 1979-10-09 1981-06-03 Mitsubishi Yuka Pharma 4-Phenylphthalazine derivatives
EP0934307B1 (en) * 1996-06-19 2011-04-27 Aventis Pharma Limited Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
IT1296984B1 (it) * 1997-12-19 1999-08-03 Zambon Spa Derivati ftalazinici inibitori della fosfodiesterasi 4
ITMI981671A1 (it) * 1998-07-21 2000-01-21 Zambon Spa Derivati ftalazinici inibitori della fosfodisterasi 4
ITMI981670A1 (it) * 1998-07-21 2000-01-21 Zambon Spa Derivati ftalazinici inibitori della fosfodiesterasi 4
DE19963607B4 (de) * 1999-12-23 2005-12-15 Schering Ag Verfahren zur Herstellung von 4-(Heteroaryl-methyl) halogen-1(2H)-phthalazinonen

Also Published As

Publication number Publication date
US20040043999A1 (en) 2004-03-04
EP1042300A1 (en) 2000-10-11
PT1042300E (pt) 2004-06-30
US6589951B1 (en) 2003-07-08
ITMI972806A1 (it) 1999-06-19
AU2613299A (en) 1999-07-12
ATE259356T1 (de) 2004-02-15
DE69821650D1 (de) 2004-03-18
ES2216354T3 (es) 2004-10-16
DE69821650T2 (de) 2004-12-23
JP2001526270A (ja) 2001-12-18
WO1999032456A1 (en) 1999-07-01
EP1042300B1 (en) 2004-02-11
DK1042300T3 (da) 2004-06-28

Similar Documents

Publication Publication Date Title
IT1296984B1 (it) Derivati ftalazinici inibitori della fosfodiesterasi 4
DE68907921D1 (de) Substituierte pyrrol-, pyrazol- und triazol-angiotensin ii-antagonisten.
EA199900953A1 (ru) ЗАМЕЩЕННЫЕ ПИРАЗОЛЫ, КАК ИНГИБИТОРЫ p38 КИНАЗЫ
TR200102001T2 (tr) P38 kinaz inhibitörleri olarak sübstitüe edilmiş pirazoller
MY119425A (en) Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
ATE292626T1 (de) Substituierte indazolderivate und ihre verwendung als inhibitoren des phosphodiesterase (pde) des typs iv und der produktion des tumor nekrosis faktors (tnf)
DK0564409T3 (da) Pyrimidinderivater og fremgangsmåde til fremstilling deraf
ATE170856T1 (de) Indolderivate als thromboxane a2 antagonisten
ES515743A0 (es) "un procedimiento para preparar derivados de piridazinona".
HUT52058A (en) Process for producing n-substituted nicotinamide derivatives
TR200101505T2 (tr) 2-(2,6-dioksopiperidin-3-il) izoindolin türevleri, bunların hazırlanması ve enflamatuar sitokinlerin inhibitörleri olarak kullanımı
GR1001619B (el) Παράγωγα ινδόλης.
RU2009128966A (ru) Новые производные аминопиримидина в качестве ингибиторов plr1
ES8505652A1 (es) Procedimiento para preparar nuevas 1-bencil-aminoalquil-pirrolidinonas
GB1351430A (en) Substituted 1,2,4-triazole derivatives
WO1999032449A3 (en) Benzazine derivatives as phosphodiesterase 4 inhibitors
ES8602783A1 (es) Un procedimiento para la preparacion de pirazolopiridinas.
EP0299683A3 (en) Heterocyclic olefinic compounds and their use as aromatase inhibitors
DE59707062D1 (de) 2,3-benzodiazepinderivate und deren verwendung als ampa-rezeptoren-hemmer
ES2021941A6 (es) Procedimiento para la preparacion de nuevos derivados de pirimidinil-piperacinil-alquil azoles.
DE69109090T2 (de) 2-substituierte 4,5-diphenylimidazole.
EP0978515A3 (en) 1-(substituted phenyl)-4-biphenylmethyl-imidazol-2-one derivatives, their preparation and their use as angiotensin II antagonists
RU94041225A (ru) Антивирусные пептиды, способ получения, фармацевтическая композиция, способ лечения ретровирусных инфекций
MX9706014A (es) Derivados de xanteno y acridina y su empleo.
DE59204004D1 (de) VERWENDUNG VON OXAZOLO- 2,3-a]ISOINDOL- UND IMIDAZO 2,1-a]ISOINDOL-DERIVATEN ALS ANTIVIRALE ARZNEIMITTEL SOWIE NEUE OXAZOLO 2,3-a]ISOINDOL-DERIVATEN.

Legal Events

Date Code Title Description
0001 Granted